Guideline Summary for Management of Symptomatic Tachycardia

Understanding Symptoms

Patients with symptomatic tachycardia experience palpitations, light‑headedness, chest discomfort, and fatigue caused by an abnormally fast heart rate; treatment targets rhythm control and removal of underlying triggers. 1
Palpitations may be described as a racing, fluttering, or “neck‑pounding” sensation, reflecting out‑of‑sync contraction of the heart chambers. 2
True syncope is uncommon in most supraventricular tachycardias, but light‑headedness is frequent, especially during the first 10–30 seconds of an episode when blood pressure falls most sharply. 2
Elderly patients are more likely to experience near‑syncope or fainting despite having slower tachycardia rates than younger individuals. 2

Immediate emergency evaluation is warranted for altered mental status, severe chest pain suggestive of myocardial infarction, sudden shortness of breath with heart‑failure signs, markedly low blood pressure, or actual loss of consciousness. 4
A heart rate exceeding 150 beats per minute generally indicates a primary rhythm disorder that requires prompt medical assessment rather than attribution to a secondary condition. 4
If a wide‑complex tachycardia (possible ventricular tachycardia) is suspected, urgent cardiology consultation is essential because of the potential for life‑threatening outcomes. 4

Approximately 57 % of patients with supraventricular tachycardia experience episodes while driving, and 24 % view this as a barrier to safe driving. 2
Among drivers who have tachycardia episodes, 77 % report fatigue, 50 % experience near‑syncope, and 14 % actually faint. 2
Patients who have had syncope or near‑syncope during tachycardia should discuss driving restrictions with their physician, as these symptoms pose the greatest safety risk. 2

Many rapid heart rates are physiological responses to reversible conditions such as fever, dehydration, anemia, pain, anxiety, caffeine, certain medications (e.g., albuterol), and illicit stimulants; the tachycardia typically resolves once the trigger is treated. 1
In inappropriate sinus tachycardia (IST), anxiety is a notable trigger; evaluation for anxiety disorders should be considered alongside heart‑rate management. 1
IST generally has a benign prognosis; therapy aims to reduce symptoms rather than achieve cure, and lowering the heart rate does not always eliminate symptoms. 1

Beta‑blockers or calcium‑channel blockers are often ineffective or poorly tolerated in IST because of side‑effects such as hypotension; ivabradine may be an alternative therapeutic option. 1
Exercise training may provide benefit for IST, although current evidence is not definitive. 1
In patients with reduced cardiac function, attempts to “normalize” the heart rate with medications can be harmful, as tachycardia may serve as a compensatory mechanism to maintain adequate perfusion. 4

For infrequent palpitations without chest pain, heart‑failure signs, or syncope, an event recorder or wearable loop recorder is preferred over a 24‑hour Holter monitor to capture rhythm during symptoms. 6
Patients with several episodes per week should undergo 24‑hour Holter monitoring; those with very rare symptoms (≤ 2 per month) but concerning features may require an implantable loop recorder. 6
The presence of a pre‑excitation pattern (Wolff‑Parkinson‑White) on resting ECG mandates prompt referral to a cardiac electrophysiologist, even if symptoms are minimal, due to specific arrhythmic risks. 2

Limit excessive caffeine intake, as it is a common exogenous trigger for tachycardia episodes. 1
Maintain adequate hydration, especially during illness or in hot environments, because dehydration frequently precipitates sinus tachycardia. 1
For patients with thyroid disease, ensure regular follow‑up and medication adherence, since hyperthyroidism is a frequent cause of persistent tachycardia. 6

Radiofrequency ablation is the most widely used technique for curative treatment of persistent or recurrent supraventricular tachycardia; cryoablation may be selected in specific scenarios to reduce the risk of injury to critical cardiac structures. 1